Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $875.0500 (1.33%) ($875.0500 - $875.0500) on Wed. Dec. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 81 | Latest Price | $875.0500(1.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.9% a day on average for past five trading days. | Weekly Trend | REGN advances 3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) SDY(66%) XLU(59%) IBB(58%) JETS(57%) SPLV(56%) | Factors Impacting REGN price | REGN will decline at least -0.56% in a week (0% probabilities). VXX(-42%) USO(-40%) UNG(-38%) XLE(-31%) VIXM(-29%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $855.35(2.3%) | 10 Day Moving Average | $840.49(4.11%) | 20 Day Moving Average | $820.85(6.6%) | To recent high | 0% | To recent low | 12.9% | Market Cap | $92.78b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |